Senitnel Lymph Biopsy in Breast Cancer: Real World Experience from a Tertiary Care Hospital in India

Abstract

Background: Sentinel lymph node biopsy (SLNBx) is the current standard of care for management of axilla in early breast cancer. Dual tracer technique is the most commonly recommended approach due to its low failure rate. In developing countries such as India, penetration of SLNBx is low due to factors such as non-availability of Isosulfan blue/Patent Blue V, lack of nuclear medicine facilities and higher disease stage at presentation. We present a real world experience of SLNBx from a tertiary care hospital in India.